CY1109371T1 - Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους - Google Patents

Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους

Info

Publication number
CY1109371T1
CY1109371T1 CY20091100937T CY091100937T CY1109371T1 CY 1109371 T1 CY1109371 T1 CY 1109371T1 CY 20091100937 T CY20091100937 T CY 20091100937T CY 091100937 T CY091100937 T CY 091100937T CY 1109371 T1 CY1109371 T1 CY 1109371T1
Authority
CY
Cyprus
Prior art keywords
benzothiophein
sulphatation
sulfamic
steroid
inhibitors
Prior art date
Application number
CY20091100937T
Other languages
English (en)
Inventor
Jean Lafay
Benoît Rondot
Denis Carniato
Paule Bonnet
Thierry Clerc
Jacqueline Shields
Igor Duc
Eric Duranti
Original Assignee
Laboratoire Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex
Publication of CY1109371T1 publication Critical patent/CY1109371T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76—Dibenzothiophenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Η παρούσα εφεύρεση αφορά ενώσεις σουλφαμκού βενζοθειοφαινίου του τύπου:Ι, όπου τα R1, R2, R3, m και n είναι όπως ορίζεται στην περιγραφή. Η εφεύρεση αφορά επίσης φαρμακευτικές συνθέσεις που περιέχουν αυτές τις ενώσεις και μεθόδους χρήσης αυτών.
CY20091100937T 2003-05-16 2009-09-09 Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους CY1109371T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2003/008811 WO2004101545A1 (en) 2003-05-16 2003-05-16 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
EP03816954A EP1644350B1 (en) 2003-05-16 2003-05-16 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors

Publications (1)

Publication Number Publication Date
CY1109371T1 true CY1109371T1 (el) 2014-07-02

Family

ID=33442621

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100937T CY1109371T1 (el) 2003-05-16 2009-09-09 Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους

Country Status (22)

Country Link
US (1) US7476691B2 (el)
EP (1) EP1644350B1 (el)
JP (1) JP4757497B2 (el)
CN (2) CN100491370C (el)
AP (1) AP2066A (el)
AT (1) ATE435221T1 (el)
AU (1) AU2003260390B2 (el)
BR (1) BR0318295A (el)
CA (1) CA2525684C (el)
CY (1) CY1109371T1 (el)
DE (1) DE60328233D1 (el)
DK (1) DK1644350T3 (el)
ES (1) ES2329241T3 (el)
HK (1) HK1087115A1 (el)
IL (1) IL171763A (el)
MX (1) MXPA05012300A (el)
NO (1) NO20055749L (el)
NZ (1) NZ544013A (el)
PT (1) PT1644350E (el)
SI (1) SI1644350T1 (el)
TN (1) TNSN05291A1 (el)
WO (1) WO2004101545A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA13336A (en) 2003-12-15 2006-04-13 Theramex 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them.
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
AU2007271486A1 (en) * 2006-07-05 2008-01-10 Merck Patent Gmbh Sulfamate benzothiophene derivatives
WO2008067892A1 (de) * 2006-12-04 2008-06-12 Merck Patent Gmbh Sulfamat-benzothiophen-derivate
BRPI0817045A2 (pt) * 2007-09-17 2015-03-24 Preglem Sa Tratamento de condições estrogênio-dependentes em mulheres pré-menopáusicas
JP2011157371A (ja) * 2011-03-17 2011-08-18 Lab Theramex ステロイドスルファターゼ阻害剤としてのベンゾチオフェンスルファミン酸塩誘導体
CN115805103B (zh) * 2021-09-14 2024-04-09 万华化学集团股份有限公司 一种失活钛硅分子筛的再生方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6248780B1 (en) * 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same

Also Published As

Publication number Publication date
AU2003260390B2 (en) 2010-05-20
CN100491370C (zh) 2009-05-27
CN101508691A (zh) 2009-08-19
ATE435221T1 (de) 2009-07-15
HK1087115A1 (en) 2006-10-06
DK1644350T3 (da) 2009-11-23
WO2004101545A1 (en) 2004-11-25
EP1644350B1 (en) 2009-07-01
CA2525684A1 (en) 2004-11-25
NO20055749L (no) 2005-12-14
SI1644350T1 (sl) 2009-12-31
DE60328233D1 (de) 2009-08-13
CN1771243A (zh) 2006-05-10
TNSN05291A1 (en) 2007-07-10
AP2005003468A0 (en) 2005-12-31
JP4757497B2 (ja) 2011-08-24
NO20055749D0 (no) 2005-12-05
US7476691B2 (en) 2009-01-13
BR0318295A (pt) 2006-07-11
IL171763A (en) 2013-09-30
AU2003260390A1 (en) 2004-12-03
ES2329241T3 (es) 2009-11-24
NZ544013A (en) 2009-04-30
CA2525684C (en) 2015-01-06
AP2066A (en) 2009-11-27
MXPA05012300A (es) 2006-01-30
US20070021492A1 (en) 2007-01-25
EP1644350A1 (en) 2006-04-12
JP2006525947A (ja) 2006-11-16
PT1644350E (pt) 2009-09-02

Similar Documents

Publication Publication Date Title
CY1116103T1 (el) Υποκατεστημενα παραγωγα 1,2,3,4-τετραϋδροϊσοκινολινης
CY1109371T1 (el) Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους
CY1110419T1 (el) Τρικυκλικες ενωσεις με βαση το 1,6-διυδρο-1,3,5,6-tetpaaza-as-ινδακενιο και φαρμακευτικες συνθεσεις που τις περιεχουν ως αναστολεις της ενζυμικης ενεργοτητας της ικκ
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
ATE433447T1 (de) Pyrimiidinverbindungen
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
HK1082250A1 (en) Thiophene carboxamides as inhibitors of the enzymeikk-2
ATE449069T1 (de) Aminopropanolderivate
SE0302139D0 (sv) Novel compounds
CY1107485T1 (el) 3-θειομεθυλπυραζoλες ως παρασιτοκτoνα
CY1109637T1 (el) Νεα τρικυκλικα παραγωγα, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
CY1106973T1 (el) Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)
SE0302116D0 (sv) Novel compounds
SE0303541D0 (sv) New compounds
UY30363A1 (es) Derivados sustituidos de la n-(3-oxo-2,3-dihidro-1h-isoindol-4-il)-1-naftamida, procesos de preparacion, composiciones farmacéuticas y aplicaciones
ATE365735T1 (de) Cycloalkylsulfanyl-substituierte benzo böthiophene als therapeutische mittel
MXPA05012953A (es) Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos.
SE0300092D0 (sv) Novel compounds
EA200600100A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
SE0303280D0 (sv) Novel compounds
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
CY1106317T1 (el) Παραγωγα 1-ν-φαινυλαμινο-1η-ιμιδαζολης, ως αναστολεις αρωματασης